93 related articles for article (PubMed ID: 2849453)
1. High affinity binding of ramiprilat on isolated human glomeruli.
Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
Biochem Pharmacol; 1988 Dec; 37(24):4679-84. PubMed ID: 2849453
[TBL] [Abstract][Full Text] [Related]
2. High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli.
Becker RH; Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S31-4. PubMed ID: 2474098
[TBL] [Abstract][Full Text] [Related]
3. [3H]ramiprilat binding to the angiotensin-converting enzyme in rat renal brush-border membranes: the effect of chloride.
Grima M; Mosser J; Welsch C; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1991 Mar; 206(3):203-9. PubMed ID: 1649762
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cells.
Baudin B; Drouet L
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S37-42. PubMed ID: 2483427
[TBL] [Abstract][Full Text] [Related]
5. Assay of tissue angiotensin converting enzyme.
Welsch C; Grima M; Giesen EM; Helwig JJ; Barthelmebs M; Coquard C; Imbs JL
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S26-31. PubMed ID: 2483425
[TBL] [Abstract][Full Text] [Related]
6. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
Levitt DG; Schoemaker RC
BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme in isolated human glomeruli.
Chansel D; Morin JP; Borghi H; Ardaillou N; Ardaillou R
FEBS Lett; 1987 Aug; 220(1):247-52. PubMed ID: 3038613
[TBL] [Abstract][Full Text] [Related]
8. Kinetic properties of the angiotensin converting enzyme inhibitor ramiprilat.
Bünning P
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S31-5. PubMed ID: 2485060
[TBL] [Abstract][Full Text] [Related]
9. Direct effects of the angiotensin-converting enzyme inhibitor ramiprilat on adult rat ventricular cardiomyocytes.
Helmig S; Schuckenböhmer P; Heger J; Euler G; Piper HM; Schlüter KD
Acta Physiol (Oxf); 2007 Dec; 191(4):267-74. PubMed ID: 17825088
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhibitors on the coordination geometries of cadmium at the metal sites in angiotensin-I-converting enzyme.
Carvalho E; Göthe PO; Bauer R; Danielsen E; Hemmingsen L
Eur J Biochem; 1995 Dec; 234(3):780-5. PubMed ID: 8575435
[TBL] [Abstract][Full Text] [Related]
12. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
Kohlstedt K; Busse R; Fleming I
Hypertension; 2005 Jan; 45(1):126-32. PubMed ID: 15569856
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses.
Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Serrano Caballero JM; Muñoz A
Vet J; 2016 Feb; 208():38-43. PubMed ID: 26639833
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.
Vago T; Bevilacqua M; Conci F; Baldi G; Ongini E; Chebat E; Monopoli A; Norbiato G
Br J Pharmacol; 1992 Nov; 107(3):821-5. PubMed ID: 1335341
[TBL] [Abstract][Full Text] [Related]
15. Vascular angiotensin conversion in humans.
Webb DJ; Collier JG
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S40-4. PubMed ID: 2438489
[TBL] [Abstract][Full Text] [Related]
16. Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat.
Baudin B; Bénéteau-Burnat B
J Enzyme Inhib; 1999; 14(6):447-56. PubMed ID: 10536878
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis.
Brée F; Hamon G; Tillement JP
Life Sci; 1992; 51(10):787-94. PubMed ID: 1325020
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
Desmoulins PO; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
[TBL] [Abstract][Full Text] [Related]
19. Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.
Brockmeier D
Int J Clin Pharmacol Ther; 1995 Dec; 33(12):631-8. PubMed ID: 8963479
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
